drug · antibody
patient view →marstacimab
Marketedupdated 2mo agoby $PFE PFIZER INC🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 1 investigational indication.
targets
Tissue factor pathway inhibitor
all catalysts(3)
approval · 3
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that